Clinical Trial Update: Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of delgocitinib 20 mg/g cream in subjects with chronic hand eczema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• delgocitinib (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Chronic Hand Eczema | Phase 1 | Status: COMPLETED